These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 4084318)

  • 1. Fumarate is the cause of the apparent ping-pong kinetics of dopamine beta-hydroxylase.
    Palatini P
    Biochem Int; 1985 Oct; 11(4):565-72. PubMed ID: 4084318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetic studies with competitive inhibitors indicate a sequential mechanism for dopamine beta-hydroxylase.
    Palatini P; Dabbeni-Sala F; Finotti P
    Biochem Int; 1984 Dec; 9(6):675-82. PubMed ID: 6525203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anion- and pH-dependent activation of the soluble form of dopamine beta-hydroxylase.
    Terland O; Flatmark T
    Biochem J; 2003 Feb; 369(Pt 3):675-9. PubMed ID: 12379149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plausible molecular mechanism for activation by fumarate and electron transfer of the dopamine beta-mono-oxygenase reaction.
    Wimalasena DS; Jayatillake SP; Haines DC; Wimalasena K
    Biochem J; 2002 Oct; 367(Pt 1):77-85. PubMed ID: 12038965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunofluorescent localization of dopamine beta-hydroxylase in tissues.
    Hartman BK; Udenfriend S
    Mol Pharmacol; 1970 Jan; 6(1):85-94. PubMed ID: 4125725
    [No Abstract]   [Full Text] [Related]  

  • 6. Mechanism of modulation of dopamine beta-monooxygenase by pH and fumarate as deduced from initial rate and primary deuterium isotope effect studies.
    Ahn N; Klinman JP
    Biochemistry; 1983 Jun; 22(13):3096-106. PubMed ID: 6882739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Observation on the properties of dopamine-beta-hydroxylase.
    Brown FC; Harralson JD
    J Neurochem; 1975 Mar; 24(3):467-70. PubMed ID: 1113122
    [No Abstract]   [Full Text] [Related]  

  • 8. Reduction of dopamine beta-monooxygenase. A unified model for apparent negative cooperativity and fumarate activation.
    Wimalasena K; Dharmasena S; Wimalasena DS; Hughbanks-Wheaton DK
    J Biol Chem; 1996 Oct; 271(42):26032-43. PubMed ID: 8824243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of dopamine-beta-hydroxylase, A copper enzyme, by bleomycin.
    Matsui H; Kato T; Yamamoto C; Takita T; Takeuchi T; Umezawa H; Nagatsu T
    J Antibiot (Tokyo); 1980 Apr; 33(4):435-40. PubMed ID: 6157665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ascaris suum NAD-malic enzyme is activated by L-malate and fumarate binding to separate allosteric sites.
    Karsten WE; Pais JE; Rao GS; Harris BG; Cook PF
    Biochemistry; 2003 Aug; 42(32):9712-21. PubMed ID: 12911313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cooperativity in the dopamine beta-monooxygenase reaction. Evidence for ascorbate regulation of enzyme activity.
    Stewart LC; Klinman JP
    J Biol Chem; 1991 Jun; 266(18):11537-43. PubMed ID: 2050664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine beta-hydroxylase: evidence against a ping-pong mechanism.
    Ljones T; Flatmark T
    FEBS Lett; 1974 Dec; 49(1):49-52. PubMed ID: 4474956
    [No Abstract]   [Full Text] [Related]  

  • 13. Interaction of dopamine-beta-monooxygenase with lipids: 1. Lipids as modulators of the catalytic activity of the enzyme.
    Boyadzhyan AS; Karagezyan KG
    Biomed Sci; 1990 Apr; 1(4):379-83. PubMed ID: 2133056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of dopamine beta-hydroxylase by 2-mercapto-1-methylimidazole.
    Rosenberg RC
    Biochim Biophys Acta; 1983 Dec; 749(3):276-80. PubMed ID: 6661441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [An acidic copper-containing protein as a mediator at the stage of electron transfer from cytochrome b-561 to dopamine-beta-monooxygenase].
    Oganesian LL; Boiadzhian AS; Petrosian SA; Mkrtchian ME; Karagezian KG
    Dokl Akad Nauk SSSR; 1991; 317(3):742-5. PubMed ID: 1954845
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibition of dopamine beta-hydroxylase by bidentate chelating agents.
    Townes S; Titone C; Rosenberg RC
    Biochim Biophys Acta; 1990 Feb; 1037(2):240-7. PubMed ID: 2306475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dihydrodipicolinate synthase from Escherichia coli: pH dependent changes in the kinetic mechanism and kinetic mechanism of allosteric inhibition by L-lysine.
    Karsten WE
    Biochemistry; 1997 Feb; 36(7):1730-9. PubMed ID: 9048556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of alternate substrates to probe the order of substrate addition to dopamine beta-hydroxylase.
    Fitzpatrick PF; Harpel MR; Villafranca JJ
    Arch Biochem Biophys; 1986 Aug; 249(1):70-5. PubMed ID: 3740855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Properties of soluble and membrane bound dopamine-beta-monooxygenase from bovine adrenal medulla cross-linked with dimethyl suberimidate.
    Miras-Portugal MT; Millaruelo A; Vara F
    Mol Cell Biochem; 1980 Dec; 33(1-2):25-33. PubMed ID: 7207467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of dopamine beta-hydroxylase by some new thiourea derivatives.
    Oyama H; Izumi H; Ozawa H
    Biochem Pharmacol; 1976 Feb; 25(3):277-80. PubMed ID: 1267825
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.